Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gert Van Assche

Showing results (261-270 of 287) with videos related to

Pageof 29
Sort By:
Journal of Crohn'S & Colitis|March 2, 2016
European Crohn's and Colitis Organisation Topical Review on Prediction, Diagnosis and Management of Fibrostenosing Crohn's DiseaseFlorian Rieder, Giovanni Latella, Fernando Magro, et al.
Journal of Crohn'S & Colitis|October 9, 2012
Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 3: special situationsGert Van Assche, Axel Dignass, Bernd Bokemeyer, et al.
The New England Journal of Medicine|September 26, 2019
Ustekinumab as Induction and Maintenance Therapy for Ulcerative ColitisBruce E Sands, William J Sandborn, Remo Panaccione, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|March 26, 2016
Treatment satisfaction, preferences and perception gaps between patients and physicians in the ulcerative colitis CARES study: A real world-based studyLaurent Peyrin-Biroulet, Gert Van Assche, Andreas Sturm, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|March 4, 2016
Burden of disease and patient-reported outcomes in patients with moderate to severe ulcerative colitis in the last 12 months - Multicenter European cohort studyGert Van Assche, Laurent Peyrin-Biroulet, Andreas Sturm, et al.
Journal of Crohn'S & Colitis|December 3, 2010
Report of the ECCO pathogenesis workshop on anti-TNF therapy failures in inflammatory bowel diseases: definitions, frequency and pharmacological aspectsMatthieu Allez, Konstantinos Karmiris, Edouard Louis, et al.
Inflammatory Bowel Diseases|January 1, 2014
Infliximab restores the dysfunctional matrix remodeling protein and growth factor gene expression in patients with inflammatory bowel diseaseMagali de Bruyn, Kathleen Machiels, Jennifer Vandooren, et al.
European Journal of Gastroenterology & Hepatology|December 1, 2016
Comparison of health-related quality of life and disability in ulcerative colitis patients following restorative proctocolectomy with ileal pouch-anal anastomosis versus anti-tumor necrosis factor therapySara van Gennep, Saloomeh Sahami, Christianne J Buskens, et al.
Lancet (London, England)|August 2, 2016
Expanded allogeneic adipose-derived mesenchymal stem cells (Cx601) for complex perianal fistulas in Crohn's disease: a phase 3 randomised, double-blind controlled trialJulián Panés, Damián García-Olmo, Gert Van Assche, et al.
Inflammatory Bowel Diseases|September 18, 2010
Phase I, double-blind, randomized, placebo-controlled, dose-escalation study of NI-0401 (a fully human anti-CD3 monoclonal antibody) in patients with moderate to severe active Crohn's diseaseC Janneke van der Woude, Pieter Stokkers, Ad A van Bodegraven, et al.
Pageof 29

Showing results (261-270 of 287) with videos related to

Sort By:
Pageof 29
Journal of Crohn'S & Colitis|March 2, 2016
European Crohn's and Colitis Organisation Topical Review on Prediction, Diagnosis and Management of Fibrostenosing Crohn's DiseaseFlorian Rieder, Giovanni Latella, Fernando Magro, et al.
Journal of Crohn'S & Colitis|October 9, 2012
Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 3: special situationsGert Van Assche, Axel Dignass, Bernd Bokemeyer, et al.
The New England Journal of Medicine|September 26, 2019
Ustekinumab as Induction and Maintenance Therapy for Ulcerative ColitisBruce E Sands, William J Sandborn, Remo Panaccione, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|March 26, 2016
Treatment satisfaction, preferences and perception gaps between patients and physicians in the ulcerative colitis CARES study: A real world-based studyLaurent Peyrin-Biroulet, Gert Van Assche, Andreas Sturm, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|March 4, 2016
Burden of disease and patient-reported outcomes in patients with moderate to severe ulcerative colitis in the last 12 months - Multicenter European cohort studyGert Van Assche, Laurent Peyrin-Biroulet, Andreas Sturm, et al.
Journal of Crohn'S & Colitis|December 3, 2010
Report of the ECCO pathogenesis workshop on anti-TNF therapy failures in inflammatory bowel diseases: definitions, frequency and pharmacological aspectsMatthieu Allez, Konstantinos Karmiris, Edouard Louis, et al.
Inflammatory Bowel Diseases|January 1, 2014
Infliximab restores the dysfunctional matrix remodeling protein and growth factor gene expression in patients with inflammatory bowel diseaseMagali de Bruyn, Kathleen Machiels, Jennifer Vandooren, et al.
European Journal of Gastroenterology & Hepatology|December 1, 2016
Comparison of health-related quality of life and disability in ulcerative colitis patients following restorative proctocolectomy with ileal pouch-anal anastomosis versus anti-tumor necrosis factor therapySara van Gennep, Saloomeh Sahami, Christianne J Buskens, et al.
Lancet (London, England)|August 2, 2016
Expanded allogeneic adipose-derived mesenchymal stem cells (Cx601) for complex perianal fistulas in Crohn's disease: a phase 3 randomised, double-blind controlled trialJulián Panés, Damián García-Olmo, Gert Van Assche, et al.
Inflammatory Bowel Diseases|September 18, 2010
Phase I, double-blind, randomized, placebo-controlled, dose-escalation study of NI-0401 (a fully human anti-CD3 monoclonal antibody) in patients with moderate to severe active Crohn's diseaseC Janneke van der Woude, Pieter Stokkers, Ad A van Bodegraven, et al.
Pageof 29